These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21466263)
1. Prognostic significance of matrix metalloproteinase-20 overexpression in laryngeal squamous cell carcinoma. Liu Y; Li Y; Liu Z; Zhang L; Anniko M; Duan M Acta Otolaryngol; 2011 Jul; 131(7):769-73. PubMed ID: 21466263 [TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Xie M; Sun Y; Li Y Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850 [TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813 [TBL] [Abstract][Full Text] [Related]
5. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. Shi Y; Gong HL; Zhou L; Tian J; Wang Y ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. Cao WF; Zhang LY; Liu MB; Tang PZ; Liu ZH; Sun BC Hum Pathol; 2007 May; 38(5):747-52. PubMed ID: 17306333 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Zhang S; Lu X Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753 [TBL] [Abstract][Full Text] [Related]
8. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells. Li DW; Zhou L; Jin B; Xie J; Dong P Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365 [TBL] [Abstract][Full Text] [Related]
9. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance and prognostic role of cyclin E and cyclin A expression in laryngeal epithelial lesions. Fraczek M; Wozniak Z; Ramsey D; Zatonski T; Krecicki T Acta Otolaryngol; 2008 Mar; 128(3):329-34. PubMed ID: 17917837 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx. Starska K; Łukomski M; Stasikowska O; Lewy-Trenda I Adv Med Sci; 2007; 52():169-73. PubMed ID: 18217412 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392 [TBL] [Abstract][Full Text] [Related]
13. [The expression of oncogene AKT2 in laryngeal squamous cell carcinoma and its clinical significance]. Chen Y; He Y; Zhang S; Li L; Zhu X; Liu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):539-41, 545. PubMed ID: 19771908 [TBL] [Abstract][Full Text] [Related]
14. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma]. Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186 [TBL] [Abstract][Full Text] [Related]
15. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis]. Wu SH; Zhang J; Li Y; Li JM Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985 [TBL] [Abstract][Full Text] [Related]
16. [The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma]. Liu Y; Qiu Y; Zhang X; Tian Y; Huang D; Zhou X; Tan P; Yu C; Qi L; Xiao J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 25(6):265-9. PubMed ID: 21650061 [TBL] [Abstract][Full Text] [Related]
17. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma]. Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240 [TBL] [Abstract][Full Text] [Related]
19. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors. Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188 [TBL] [Abstract][Full Text] [Related]
20. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma]. Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]